Clinical trial Recruiting at 1 site Interventional Ages 4 Months to 2

Different early-intervention models for premature infants using the ICF biopsychosocial approach

Official title: Analysis of the Impact of Different Intervention Models on the Neuropsychomotor Development of Premature Infants Based on the ICF Biopsychosocial Model

Run by Federal University of Health Science of Porto Alegre · NCT05989438 · Data updated 2026-11-12

This project will test whether different early-intervention approaches based on the ICF biopsychosocial model help improve neuropsychomotor development in babies born premature.

Quick facts

Study typeInterventional
Ages4 Months to 2 Years
SexAll
Enrollment60 (estimated)
SponsorFederal University of Health Science of Porto Alegre
Academic / other
Locations1 site (Porto Alegre, Rio Grande do Sul)
StatusRecruiting
StartedAugust 1, 2023
Main results expectedJune 2025
Study endsJanuary 11, 2026
Registry record updatedJune 25, 2025
Trial IDNCT05989438 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants born before 37 weeks gestation who are registered at the UFCSPA High Risk Outpatient Clinic, are between about 4 and 12 months corrected age at enrollment, and whose caregivers provide informed consent.

Probably not a fit

Infants with major neurological injury (e.g., grade IV hemorrhage), genetic syndromes, significant cardiac or musculoskeletal conditions, uncontrolled seizures, or those unable to complete baseline and final evaluations are unlikely to benefit from these specific interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Premature infants seen at the UFCSPA High Risk Outpatient Clinic are randomized to receive either family-guidance only or therapist-led stimulation plus family guidance using the ICF biopsychosocial framework. Participants are enrolled between corrected ages of about 4 to 12 months and followed with evaluations through roughly 24 months corrected age. The trial focuses on functional neuropsychomotor outcomes and uses standardized developmental and functional measures to compare the two intervention models. The aim is to standardize approaches to early intervention that prioritize functionality and family support.

Why it matters

Potential benefit: If successful, the interventions could lead to more targeted early-intervention programs that improve motor skills and everyday functioning for premature infants.

How similar studies have gone: Family-centered early intervention and physiotherapy approaches have shown benefit for preterm motor development in prior work, but randomized interventions explicitly framed and reported using the ICF biopsychosocial model remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Gestational age less than 37 weeks, corrected age between 4 and 12 months (one and a half month window) and at 24 months (four months window)
* Babies from the High Risk Outpatient Clinic of the UCS Clinical Center, registered there;
* Authorization of those responsible for the minor consenting to participation in the study by signing the Free and Informed Consent Form (TCLE).

Exclusion Criteria:

* All those subjects who do not follow the items mentioned above;
* Presenting neurological diseases;
* Presence of acute diseases (eg pneumonia, bronchiolitis, trauma)
* Musculoskeletal alterations;
* Genetic syndromes;
* In genetic investigation;
* Heart diseases with indication for surgical intervention;
* Untreated congenital torticollis;
* Congenital clubfoot;
* Cerebral hemorrhage grade IV
* Those who do not undergo the first and/or last evaluation;
* Incomplete evaluation;
* Convulsive crisis during study period;
* Participants from other intervention programs.

Where it's running

  • Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
    Porto Alegre, Rio Grande do Sul, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.